Melanotan II

Melanotan II is a synthetic version of the hormone that tells skin to produce pigment. Unlike most compounds in this section, it does visibly work, and quickly.

That is exactly why it deserves a careful read rather than a dismissal, and why the note at the foot of this page is the most important thing on it.

Why people are talking about it#

Because it does what it says. A deep tan from a compound rather than from weeks of sun is a striking proposition, and the effect is fast enough that people notice within days.

The other effects are the reason it has a second reputation. Increased arousal is widely reported, and that is not a coincidence: bremelanotide, the approved desire medicine, is a close relative developed from the same research with the tanning activity engineered out.

What people take it for#

Tanning, mostly. Increased arousal and reduced appetite are commonly reported alongside.

Tanning#

The claim is a deep tan with minimal sun. The mechanism is agonism at the MC1R receptor on melanocytes, the cells that make pigment, which is the same receptor the body's own alpha-MSH acts on.

In practice that describes switching on pigment production directly rather than waiting for ultraviolet damage to trigger it. The effect is real, visible and fast.

Arousal#

The claim is stronger and more frequent arousal, through activity at MC4R in the brain, the same receptor bremelanotide was designed around.

What that looks like in practice includes spontaneous erections, which users report frequently and which is the reason the related compound became a medicine.

Appetite suppression#

The claim is eating less without trying. Melanocortin signalling is genuinely involved in appetite regulation, and MC4R is one of the best-established appetite pathways in human genetics.

The mechanism is real; no trial has quantified appetite or weight change with this compound.

What the evidence shows#

The pigmentation effect is real and well described. There is no completed efficacy trial for cosmetic tanning and no established dose, because no regulator has been asked to approve it for that.

The dermatology literature is where the substantive findings are. It includes case reports of existing moles darkening, new ones appearing, and melanoma diagnosed in users. Those reports cannot prove cause, and they describe a plausible mechanism attached to a specific harm.

Nausea and flushing are close to universal in the first days. Published case reports have also described rhabdomyolysis, kidney injury and priapism.

How it is taken#

Protocols in circulation describe a loading period of daily subcutaneous injection until the desired colour is reached, followed by less frequent maintenance dosing, often combined with some ultraviolet exposure.

Those schedules come from community practice rather than clinical work. The ultraviolet component is worth noticing: the routine that produces the fastest result is also the one that adds back the exposure people took the compound to avoid.

Nasal spray versions are widely sold. The route changes the delivery, not the pharmacology or the effect on moles.

How it compares#

Against sunbeds and sun exposure#

Both cause pigmentation through ultraviolet damage, which is a known carcinogen. Melanotan II avoids that particular route and introduces a different set of concerns centred on melanocyte stimulation.

Against fake tan#

Topical dihydroxyacetone products colour the dead outer layer of skin and do not interact with melanocytes at all. Cosmetically some people find them inferior, and they are not associated with any of the concerns on this page.

Against bremelanotide#

Bremelanotide came out of the same research programme with the tanning activity removed, went through trials, and was approved. It is what this compound looks like when it is developed properly.

Against Melanotan I#

Melanotan I is the selective version and is an approved medicine as an implant for a rare light-sensitivity disease. It does not produce the arousal or appetite effects, and the mole question applies to both equally.

Common questions#

Does it actually work?

Yes, visibly and quickly, which distinguishes it from most of this category.

Is the nasal spray gentler?

No. The route changes how it gets in, not what it does once there.

Why does it affect arousal?

It acts at MC4R in the brain as well as MC1R in the skin. Bremelanotide was built by keeping the first and removing the second.

What should I watch for?

Changes in moles, and any new pigmented spot. That is the finding the whole dermatology literature on this compound is about.